Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Comen
Larry Norton

Showing results (21-30 of 297) with videos related to

Pageof 30
Sort By:
Current Oncology Reports|December 22, 2004
Two regimens of docetaxel for metastatic breast cancerAndrew D Seidman, Larry Norton
The New England Journal of Medicine|September 20, 2013
Acquired resistance to crizotinib from a mutation in CD74-ROS1Marco Gerlinger, Larry Norton, Charles Swanton
Annals of Global Health|February 27, 2023
Global Oncology Medical Diplomacy Working Group Inaugural Meeting: Defining Worldwide Barriers to Germline Genomics in Cancer Prevention and ManagementGhassan K Abou-Alfa, Larry Norton,
Journal of the National Cancer Institute|July 18, 2013
Epoetin alfa: to give or not to giveChau Dang, Clifford Hudis, Larry Norton
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2008
Dose-dense chemotherapy with trastuzumab is an appropriate optionChau Dang, Larry Norton, Clifford Hudis
Iscience|February 9, 2024
Preoperative immune checkpoint inhibition and cryoablation in early-stage breast cancerElizabeth Comen, Sadna Budhu, Yuval Elhanati, et al.
Nature Reviews. Clinical Oncology|January 28, 2015
Current management of lesions associated with an increased risk of breast cancerMonica Morrow, Stuart J Schnitt, Larry Norton
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2011
Breast cancer tumor size, nodal status, and prognosis: biology trumps anatomyElizabeth A Comen, Larry Norton, Joan Massagué
Clinical Breast Cancer|September 26, 2016
A Rare Case of S310F Somatic ERBB2 Mutation in a HER2-Nonamplified Breast CancerSakshi Jasra, Mateusz Opyrchal, Larry Norton, et al.
Genes & Development|February 4, 2011
MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancerKim J Png, Mitsukuni Yoshida, Xiang H-F Zhang, et al.
Pageof 30

Showing results (21-30 of 297) with videos related to

Sort By:
Pageof 30
Current Oncology Reports|December 22, 2004
Two regimens of docetaxel for metastatic breast cancerAndrew D Seidman, Larry Norton
The New England Journal of Medicine|September 20, 2013
Acquired resistance to crizotinib from a mutation in CD74-ROS1Marco Gerlinger, Larry Norton, Charles Swanton
Annals of Global Health|February 27, 2023
Global Oncology Medical Diplomacy Working Group Inaugural Meeting: Defining Worldwide Barriers to Germline Genomics in Cancer Prevention and ManagementGhassan K Abou-Alfa, Larry Norton,
Journal of the National Cancer Institute|July 18, 2013
Epoetin alfa: to give or not to giveChau Dang, Clifford Hudis, Larry Norton
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2008
Dose-dense chemotherapy with trastuzumab is an appropriate optionChau Dang, Larry Norton, Clifford Hudis
Iscience|February 9, 2024
Preoperative immune checkpoint inhibition and cryoablation in early-stage breast cancerElizabeth Comen, Sadna Budhu, Yuval Elhanati, et al.
Nature Reviews. Clinical Oncology|January 28, 2015
Current management of lesions associated with an increased risk of breast cancerMonica Morrow, Stuart J Schnitt, Larry Norton
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2011
Breast cancer tumor size, nodal status, and prognosis: biology trumps anatomyElizabeth A Comen, Larry Norton, Joan Massagué
Clinical Breast Cancer|September 26, 2016
A Rare Case of S310F Somatic ERBB2 Mutation in a HER2-Nonamplified Breast CancerSakshi Jasra, Mateusz Opyrchal, Larry Norton, et al.
Genes & Development|February 4, 2011
MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancerKim J Png, Mitsukuni Yoshida, Xiang H-F Zhang, et al.
Pageof 30